FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979761529> ?p ?o ?g. }

• W1979761529 endingPage "1031" @default.
• W1979761529 startingPage "1024" @default.
• W1979761529 abstract "Levels of 15 guanidino compounds and urea were determined in serum and urine of nondialyzed patients with chronic renal insufficiency subdivided according to etiology and creatinine clearances. No significantly different guanidino compound levels in serum and urine were found for the interstitial nephritis, glomerulonephritis, nephrangiosclerosis, and diabetic nephropathy subgroups. Subdividing the patients according to creatinine clearance yields the following results: (1) Serum guanidinosuccinic acid (GSA) and methylguanidine levels of patients with end-stage renal failure (creatinine clearance < 10 mL/min) are up to 100 and 35 times higher than control levels, while guanidine, creatinine, and symmetrical dimethylarginine (SDMA) are increased about 10 times. Serum levels of asymmetrical dimethylarginine (ADMA) are only doubled in end-stage renal failure. Serum levels of guanidinoacetic acid (GAA) and homoarginine are significantly decreased. (2) Urinary excretion levels of most guanidino compounds decrease with decreasing creatinine clearance except for GSA and methylguanidine. (3) Greater than 90% of patients with creatinine clearance ranging from subnormal to 40 mL/min have serum SDMA levels higher than the upper-normal limit; up to 80% have increased GSA levels. (4) The clearance rates of some of the guanidino compounds could be calculated: with the exception of arginine, they decrease with decreasing creatinine clearance. This study shows specific abnormal guanidino compound levels in serum and urine of nondialyzed patients with chronic renal insufficiency that can be used as complementary diagnostic parameters. The best correlation between serum guanidino compound levels and the degree of renal insufficiency is found for GSA, SDMA, methylguanidine, and guanidine. Urinary excretion levels of ADMA correlate best with decreasing creatinine clearance. Serum levels of GSA and especially SDMA are candidate indicators for the onset of renal failure." @default.
• W1979761529 created "2016-06-24" @default.
• W1979761529 creator A5003850447 @default.
• W1979761529 creator A5027033208 @default.
• W1979761529 creator A5030665830 @default.
• W1979761529 creator A5050584460 @default.
• W1979761529 creator A5059875069 @default.
• W1979761529 creator A5074136919 @default.
• W1979761529 creator A5076282187 @default.
• W1979761529 creator A5076828348 @default.
• W1979761529 date "1997-09-01" @default.
• W1979761529 modified "2023-10-14" @default.
• W1979761529 title "Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency" @default.
• W1979761529 cites W1550111394 @default.
• W1979761529 cites W1818594426 @default.
• W1979761529 cites W1968143909 @default.
• W1979761529 cites W1980741553 @default.
• W1979761529 cites W1995833634 @default.
• W1979761529 cites W2010707246 @default.
• W1979761529 cites W2024862570 @default.
• W1979761529 cites W2025307836 @default.
• W1979761529 cites W2027866422 @default.
• W1979761529 cites W2030194829 @default.
• W1979761529 cites W2045138089 @default.
• W1979761529 cites W2058385357 @default.
• W1979761529 cites W2060505125 @default.
• W1979761529 cites W2063707977 @default.
• W1979761529 cites W2065035447 @default.
• W1979761529 cites W2066191738 @default.
• W1979761529 cites W2069183831 @default.
• W1979761529 cites W2073133399 @default.
• W1979761529 cites W2079509182 @default.
• W1979761529 cites W2110636377 @default.
• W1979761529 cites W2116014305 @default.
• W1979761529 cites W2145949470 @default.
• W1979761529 cites W2146054897 @default.
• W1979761529 cites W2149838069 @default.
• W1979761529 cites W2164607220 @default.
• W1979761529 cites W2253245114 @default.
• W1979761529 cites W23020893 @default.
• W1979761529 cites W2340560412 @default.
• W1979761529 cites W2416806605 @default.
• W1979761529 cites W2751913139 @default.
• W1979761529 cites W4249329514 @default.
• W1979761529 doi "https://doi.org/10.1016/s0026-0495(97)90273-0" @default.
• W1979761529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9284891" @default.
• W1979761529 hasPublicationYear "1997" @default.
• W1979761529 type Work @default.
• W1979761529 sameAs 1979761529 @default.
• W1979761529 citedByCount "154" @default.
• W1979761529 countsByYear W19797615292012 @default.
• W1979761529 countsByYear W19797615292013 @default.
• W1979761529 countsByYear W19797615292014 @default.
• W1979761529 countsByYear W19797615292015 @default.
• W1979761529 countsByYear W19797615292016 @default.
• W1979761529 countsByYear W19797615292017 @default.
• W1979761529 countsByYear W19797615292018 @default.
• W1979761529 countsByYear W19797615292019 @default.
• W1979761529 countsByYear W19797615292020 @default.
• W1979761529 countsByYear W19797615292021 @default.
• W1979761529 countsByYear W19797615292022 @default.
• W1979761529 crossrefType "journal-article" @default.
• W1979761529 hasAuthorship W1979761529A5003850447 @default.
• W1979761529 hasAuthorship W1979761529A5027033208 @default.
• W1979761529 hasAuthorship W1979761529A5030665830 @default.
• W1979761529 hasAuthorship W1979761529A5050584460 @default.
• W1979761529 hasAuthorship W1979761529A5059875069 @default.
• W1979761529 hasAuthorship W1979761529A5074136919 @default.
• W1979761529 hasAuthorship W1979761529A5076282187 @default.
• W1979761529 hasAuthorship W1979761529A5076828348 @default.
• W1979761529 hasConcept C10146269 @default.
• W1979761529 hasConcept C126322002 @default.
• W1979761529 hasConcept C126894567 @default.
• W1979761529 hasConcept C134018914 @default.
• W1979761529 hasConcept C159641895 @default.
• W1979761529 hasConcept C185592680 @default.
• W1979761529 hasConcept C2780026642 @default.
• W1979761529 hasConcept C2780306776 @default.
• W1979761529 hasConcept C71924100 @default.
• W1979761529 hasConcept C77411442 @default.
• W1979761529 hasConceptScore W1979761529C10146269 @default.
• W1979761529 hasConceptScore W1979761529C126322002 @default.
• W1979761529 hasConceptScore W1979761529C126894567 @default.
• W1979761529 hasConceptScore W1979761529C134018914 @default.
• W1979761529 hasConceptScore W1979761529C159641895 @default.
• W1979761529 hasConceptScore W1979761529C185592680 @default.
• W1979761529 hasConceptScore W1979761529C2780026642 @default.
• W1979761529 hasConceptScore W1979761529C2780306776 @default.
• W1979761529 hasConceptScore W1979761529C71924100 @default.
• W1979761529 hasConceptScore W1979761529C77411442 @default.
• W1979761529 hasIssue "9" @default.
• W1979761529 hasLocation W19797615291 @default.
• W1979761529 hasLocation W19797615292 @default.
• W1979761529 hasOpenAccess W1979761529 @default.
• W1979761529 hasPrimaryLocation W19797615291 @default.
• W1979761529 hasRelatedWork W171050414 @default.
• W1979761529 hasRelatedWork W2006303571 @default.
• W1979761529 hasRelatedWork W2042480476 @default.

• next